Cardiovascular Systems, Inc. Reports Fiscal 2021 First-Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/25/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Outlook Therapeutics (OTLK) halted, news pending
Cardiovascular Systems (CSII) Tops Q1 EPS by 17c
November 4, 2020 5:06 PM ESTCardiovascular Systems (NASDAQ: CSII) reported Q1 EPS of ($0.05), $0.17 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $60.5 million versus the consensus estimate of $56.29 million.
For earnings history and earnings-related data on Cardiovascular Systems (CSII) click here.
... More